Depleted uranium biological effects: Introduction and early In Vitro and In Vivo studies

Depleted Uranium: Properties, Uses, and Health Consequences

Volumn , Issue , 2006, Pages 1-20

  McClain, David E ^a   Miller, Alexandra C ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014245724     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Archer, V.E., Wagoner, J.K., Lundin, F.E., Cancer mortality among uranium mill workers, J. Occup. Med. 15: 11-14, 1973.
2. ATSDR, Toxicological Profile for Uranium, U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA, 1999.
3. Barber, D.S., Ehrlich, M.F., Jortner, B.S., The effects of stress on the temporal and regional distribution of uranium in rat brain after acute uranyl acetate exposure, J. Toxicol. Environ. Health, Part A, 68: 99-111, 2005.
4. BEIR IV: Health risks of radon and other internally deposited alpha emitters, Committee on the Biological Effects of Ionizing Radiations, National Research Council, National Academy Press, Washington, DC, 1988.
5. Blantz, R.C., The mechanism of acute renal failure after uranyl nitrate, J. Clin. Invest. 55: 621-635, 1975.
6. Bosque, M.A., Domingo, J.L., Llobet, J.M., Corbella, J., Embryotoxicity and teratogenicity of uranium in mice following SC administration of uranyl acetate, Biol. Trace Element Res. 36: 109-118, 1993.
7. Brand, K.G., Buoen, L.C., Johnson, K.H., Brand, T., Etiological factors, stages, and the role of the foreign body in foreign-body tumorigenesis: a review, Cancer Res. 35: 279-286, 1975.
8. Briner, W., Murray, J., Effects of short-term and long-term uranium exposure on open-field behavior and brain lipid peroxidation in rats, Neurotoxicol. Teratol. 27: 135-143, 2005.
9. CDC, Cross-Sectional Exposure Assessment of Environmental Contaminants in Churchill County, Nevada, Centers for Disease Control and Prevention, Atlanta, GA, 2003.
10. Coen, N., Mothersill, C., Kadhim, M., Wright, E.G., Heavy metals of relevance to human health induce Genomic Instability. J. Patholo. Oct. 195(3) 293-299.
11. Diamond, G.L., Biological consequences of exposure to soluble forms of natural uranium, Radiat. Prot. Dosimetry 26: 23-33, 1989.
12. Domingo, J.L., Llobet, J.M., Tomas, J.M., Corbella, J., Acute toxicity of uranium in rats and mice, Bull. Environ. Contam. Toxicol. 39: 168-174, 1987.
13. Domingo, J.L., Paternain, J.L., Llobet, J.M., Corbella J., Evaluation of the perinatal and postnatal effects of uranium in mice upon oral administration, Arch. Environ. Health 44: 395-398, 1989.
14. Domingo, J.L., Colomina, M.T., Llobet, J.M., Jones, M.M., Singh, P.K., The action of chelating agents in experimental uranium intoxication in mice: variations with structure and time of administrations, Fundam. Appl. Toxicol. 19: 350-357, 1992.
15. Domingo, J.L., Chemical toxicity of uranium, Toxicol. Ecotoxicol. News 2: 74-78, 1995.
16. Domingo, J.L., Reproductive and developmental toxicity of uranium and depleted uranium: a review, Reprod. Toxicol. 15: 603-609, 2001.
17. Dupree, E.A., Watkins, J.P., Ingle, J.N., Wallace, P.W., West, C.M., Tankersley, W.G., Uranium dust exposure and lung cancer risk in four processing operations, Epidemiology 6: 370-375, 1995.
18. Guglielmotti, M.B., Ubios, A.M., Larumbe, J., Cabrini, R.L., Tetracycline in uranyl nitrate intoxication: its action on renal damage and U retention in bone, Health Phys. 57: 403-405, 1989.
19. Hahn, F.F., Guilmette, R.A., Hoover, M.D., Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats, Environ. Health Perspect. 110: 51-59, 2002.
20. Hartmann, H.M., Monette, F.A., Avci, H.I., Overview of toxicity data and risk assessment methods for evaluating the chemical effects of depleted uranium compounds, Hum. Ecol. Risk Assessment 6: 851-874, 2000.
21. Heath, J.C., Cobalt as a carcinogen, Nature 173: 822-823, 1954.
22. Heath, J.C., The production of malignant tumors by cobalt in the rat, Br. J. Cancer 10: 668-673, 1956.
23. Heath, J.C., Daniel, M.R., The production of malignant tumors by nickel in the rat, Br. J. Cancer 18: 261-264, 1964.
24. Hodge, H.C., A history of uranium poisoning (1824-1942), In: Uranium, plutonium, transplutonic elements, Handbook of Experimental Pharmacology, Vol. 36, H.C. Hodge, J.N. Stannard, J.B. Hursh (Eds.), Springer-Verlag, New York, 1973b, pp. 5-69.
25. Hu, Q., Zhu, S., Induction of chromosomal aberrations in male mouse germ cells by uranyl fluoride containing enriched uranium, Mutation Res. 244: 209-214, 1999.
26. Huang, X., Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal, Mutation Res. 533: 153-171, 2003.
27. IARC, Overall Evaluation of Carcinogenicity, IARC monographs on the evaluation of carcinogenic risk of chemicals to humans, Supplement 7, Lyon, France, International Agency for Research on Cancer, 1987, 440 pp.
28. ICRP, Age-dependent doses to members of the public from the intake of radionuclides, Part 3. Ingestion dose coefficients, Publication 69 of the International Commission on Radiological Protection, Pergamon Press, Oxford, 1995.
29. Institute of Medicine, Gulf War and Health, Vol. 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, Vaccines, Committee on Health Effects Associated with Exposures During the Gulf War, Institute of Medicine, National Academy Press, Washington, DC, 2000.
30. Kalinich, J.F., Emond, C.A., Dalton, T.K., Mog, S.R., Coleman, G.D., Kordell, J.E., Miller, A.C., McClain, D.E., Embedded weapons-grade tungsten alloy shrapnel rapidly induces metastatic high-grade rhabdomyosarcomas in F344 rats, Environ. Health Perspect. 113: 729-734, 2005.
31. Kasprzak, K.S., Gabryel, P., Jarczewska, K., Carcinogenicity of nickel (II) hydroxides and nickel (II) sulfate in Wistar rats and its relation to the in vitro dissolution rates, Carcinogenesis 4: 275-279, 1983.
32. Kathren, R.L., Moore, R.H., Acute accidental inhalation of U: a 38-year follow-up, Health Phys. 51: 609-619, 1986.
33. Kocher, D.C., Relationship between kidney burden and radiation dose from chronic ingestion of U: implications for radiation standards for the public, Health Phys. 57: 9-15, 1989.
34. La Touche, Y.D., Willis, D.L., Dawydiak, O.I., Absorption and biokinetics of U in rats following oral administration of uranyl nitrate solution, Health Phys. 53: 147-162, 1987.
35. Leggett, R.W., Basis for the ICRP’s age-specific biokinetic model for uranium, Health Phys. 67: 589-610, 1994.
36. Leggett, R.W., The behavior and chemical toxicity of U in the kidney: a reassessment, Health Phys. 57: 365-383, 1989.
37. Leggett, R.W., Pellmar, T.C., The biokinetics of uranium migrating from embedded DU fragments, J. Environ. Radioact. 64: 205-225, 2003.
38. Lin, R.H., Fu, W.M., Lin-Shiau, S.Y., Presynaptic action of uranyl nitrate on the phrenic nerve-diaphragm preparation of the mouse, Neuropharmacology 27: 857-863, 1988.
39. Lin, R.H., Wu, L.J., Lee, C.H., Lin-Shiau, S.Y., Cytogenetic toxicity of uranyl nitrate in Chinese hamster ovary cells, Mutation Res. 319: 197-203, 1991.
40. Lison, D., Lauwerys, R., Study of the mechanism responsible for the elective toxicity of tungsten-carbide-cobalt powder toward macrophages, Toxicol. Lett. 60: 203-210, 1997.
41. Loomis, D.P., Wolf, S.H., Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947-1990, Am. J. Ind. Med. 29: 131-141, 1996.
42. Maynard, E.A., Hodge, H.C., Studies of the toxicity of various uranium compounds when fed to experimental animals, in C. Voeglen (Ed.), Pharmacology and Toxicology of Uranium Compounds, Vol. I, McGraw-Hill, New York, 1949, pp. 309-376.
43. Maynard, E.A., Downs, W.L., Hodge, H.C., Oral toxicity of uranium compounds, in C. Voeglen, H.C. Hodge (Eds.), Pharmacology and Toxicology of Uranium Compounds, Vol. III., McGraw-Hill, New York, 1953, 1221-1369.
44. Martin, F., Earl, R., Tawn, E.J., A cytogenetic study of men occupationally exposed to uranium, Br. J. Ind. Med. 48: 98-102, 1991.
45. McDiarmid, M.A., Keogh, J.P., Hooper, F.J., McPhaul, K., Squibb, K.S., Kane, R., DiPino, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Hamilton, M., Jacobson-Kram, D., Burrows, B., Walsh, M., Health Effects of depleted uranium on exposed Gulf War veterans, Environ. Res., Section A 82: 168-180. 2000.
46. McDiarmid, M.A., Squibb, K.S., Engelhardt, S., Oliver, M., Gucer, P., Wilson, P.D., Kane, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Jacobson-Kram, D., Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged “friendly fire” cohort, J. Occup. Environ. Med. 43: 991-1000, 2001.
47. McDiarmid, M.A., Engelhardt, S., Oliver, M., Gucer, P., Wilson, P.D., Kane, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Handwerger, B., Albertini, R.J., Jacobson-Kram, D., Thorne, C.D., Squibb, K.S., Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up, J. Toxicol. Environ. Health, Part A 67: 277-296, 2004.
48. Miller, A.C., Fuciarelli, A.F., Jackson, W.E., Ejnik, J.W., Emond, C.A., Strocko, S., Hogan, J., Page, N., Pellmar, T., Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets, Mutagenesis 13: 643-648, 1998a.
49. Miller, A.C., Blakely, W.F., Livengood, D., Whittaker, T., Xu, J., Ejnik, J.W., Hamilton, M.M., Parlette, E., John, T.S., Gerstenberg, H.M., Hsu, H., Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride, Environ. Health Perspect. 106: 465-471, 1998b.
50. Miller, A.C., Xu, J., Stewart, M., Emond, C., Hodge, S., Matthews, C., Kalinich, J., McClain, D., Potential health effects of the heavy metals, depleted uranium and tungsten, used in armor-piercing munitions: comparison of neoplastic transformation, mutagenicity, genomic instability, and oncogenesis, Metal Ions 6: 209-211, 2000.
51. Miller, A.C., Mog, S., McKinney, L., Luo, L., Allen, J., Xu, J., Page, N., Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy-metal tungsten-alloy metals: induction of genotoxic effects, Carcinogenesis 22: 115-125, 2001.
52. Miller, A.C., Xu, J., Prasanna, P.G.S., Page, N., Potential late health effects of the heavy metals, depleted uranium and tungsten, used in armor piercing munitions: comparison of neoplastic transformation and genotoxicity using the known carcinogen nickel, Mil. Med. 167: 120-122, 2002a.
53. Miller, A.C., Xu, J., Stewart, M., Brooks, K., Hodge, S., Shi, L., Page, N., McClain, D., Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints, Radiat. Prot. Dosimetry 99: 275-278, 2002b.
54. Miller, A.C., Brooks, K., Smith, J., Page, N., Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation. J. Environ. Radioact., 64(2-3): 247-259, 2003.
55. Miller, A.C., Brooks, K., Smith, J., Page, N., Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human liver carcinoma cells (HepG2), Mol Cell Biochem 255: 247-256, 2004.
56. Miller, A.C., Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium. Mol Cell Biochem 279(1-2): 97-104, 2005.
57. Morrow, P., Gelein, R., Beiter, H., Scott, J., Picano, J., Yuile, C., Inhalation and intravenous studies of UF6/UO2F in dogs, Health Phys. 43: 859-873, 1982.
58. Neuman, W.F., Fleming, R.W., Dounce, A.L., Carlson, A.B., O’Leary, J., Mulryan, B.J., Distribution and secretion of injected uranium, J. Biol. Chem. 173: 737-748, 1948a.
59. Neuman, W.F., Neuman, M.W., Mulryan B.J., The deposition of uranium in bone: I Animal studies, J. Biol. Chem. 175: 705-709, 1948b.
60. Neuman, W.F., Neuman, M.W., The deposition of uranium in bone: II Radioautographic studies, J. Biol. Chem. 175: 711-714, 1948c.
61. Ortega, A., Domingo, J.L., Llobet, J.M., Tomas, J.M., Paternain, J.L., Evaluation of the oral toxicity of uranium in a 4-week drinking-water study in rats, Bull. Environ. Contam. Toxicol. 42: 935-941, 1989.
62. Pellmar, T.C., Fuciarelli, A.F., Ejnik, J.W., Hamilton, M., Hogan, J., Strocko, S., Emond, C., Mottaz, H.M., Landauer, M.R., Distribution of uranium in rats implanted with depleted uranium pellets, Toxicol. Sci. 49: 29-39, 1999a.
63. Pellmar, T.C., Keyser, D.O., Emery, C., Hogan, J.B., Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments, Neurotoxicology 20: 785-792, 1999b.
64. Sandow, A., Isaacson, A., Topochemical factors in potentiation of contraction by heavy metal cations, J. Gen. Physiol. 49: 937-961, 1996.
65. Sunderman, F.W., Jr., Maenza, R.M., Comparisons of carcinogenicities of nickel compounds in rats, Res. Commun. Chem. Pathol. Pharmacol. 14: 319-330, 1976.
66. Sunderman, F.W., Jr., Maenza, R.M., Alpass, P.R., Mitchell, J.M., Damjanov, L., Goldbalatt, P.J., Carcinogenicity of nickel subsulfide in Fischer rats and Syrian hamsters after administration by various routes, Adv. Exp. Med. Biol. 91: 57-67, 1977.
67. Sunderman, F.W., Jr., Carcinogenicity of metal alloys in orthopedic prostheses: clinical and experimental studies, Fundam. Appl. Toxicol. 13: 205-216, 1989.
68. The Royal Society, The health hazards of depleted uranium munitions. Part I. Radiological effects, The Royal Society, London, 2001.
69. The Royal Society, The health hazards of depleted uranium munitions. Part II. Non-radiological effects and environmental impact, The Royal Society, London, 2002.
70. Voeglen, C., Pharmacology and toxicology of uranium compounds, Vol. I, C. Voeglen (Ed.), McGraw-Hill, New York, pp. 309-376, 1949.
71. Voeglen, C., Pharmacology and toxicology of uranium compounds, Vol. III, C. Voeglen, H.C. Hodge (Eds.), McGraw-Hill, New York, pp. 1221-1369, 1953.
72. Wagoner, J.K., Archer, V.E., Lundin, F.E., Jr., Holaday, D.A., Lloyd, J.W., Radiation as the cause of lung cancer among uranium miners, New Engl. J. Med. 273: 181-188.
73. Wrenn, M.E., Durbin, P.W., Howard, B., Lipszten, J., Rundo, J., Still, E.T., Willis, D.L., Metabolism of ingested U and Ra, Health Phys. 48: 601-633.